[Thrombotic thrombocytopenic purpura -- a rare complication associated with clopidogrel therapy. A case report]
Konstanty Szułdrzyński1, Jerzy Dropiński, Wojciech Szczeklik
1II Katedra Chorób Wewnetrznych, Colleium Medicum, Uniwersytet Jagielloński, Kraków. konstantys@op.pl
Abstract:
Clopidogrel -- a popular antiplatelet drug widely used in treatment of various vascular diseases -- is known for its favourable safety profile. Thrombotic thrombocytopenic purpura (TTP) is very rare but serious adverse reaction associated with clopidogrel. We present a case of patient treated with clopidogrel who developed moderate TTP with leukopenia and symptoms of haemorrhagic diathesis.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction


